In Vivo Imaging Systems Search Results


fmt 4000 fluorescence tomography in vivo imaging system  (Revvity)
92
Revvity fmt 4000 fluorescence tomography in vivo imaging system
Fmt 4000 Fluorescence Tomography In Vivo Imaging System, supplied by Revvity, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fmt 4000 fluorescence tomography in vivo imaging system/product/Revvity
Average 92 stars, based on 1 article reviews
fmt 4000 fluorescence tomography in vivo imaging system - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier
ivscope8200 small animal imaging system  (Clinx Science)
95
Clinx Science ivscope8200 small animal imaging system
Ivscope8200 Small Animal Imaging System, supplied by Clinx Science, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ivscope8200 small animal imaging system/product/Clinx Science
Average 95 stars, based on 1 article reviews
ivscope8200 small animal imaging system - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier
ivis imaging instrument  (Revvity)
95
Revvity ivis imaging instrument
Ivis Imaging Instrument, supplied by Revvity, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ivis imaging instrument/product/Revvity
Average 95 stars, based on 1 article reviews
ivis imaging instrument - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier
ivis spectrumct in vivo imaging system  (Revvity)
93
Revvity ivis spectrumct in vivo imaging system
Ivis Spectrumct In Vivo Imaging System, supplied by Revvity, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ivis spectrumct in vivo imaging system/product/Revvity
Average 93 stars, based on 1 article reviews
ivis spectrumct in vivo imaging system - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
interactive video information system lumina series iii in vivo imaging system  (Revvity)
96
Revvity interactive video information system lumina series iii in vivo imaging system
Interactive Video Information System Lumina Series Iii In Vivo Imaging System, supplied by Revvity, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/interactive video information system lumina series iii in vivo imaging system/product/Revvity
Average 96 stars, based on 1 article reviews
interactive video information system lumina series iii in vivo imaging system - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier
ivis lumina xrms series iii  (Revvity)
92
Revvity ivis lumina xrms series iii
Ivis Lumina Xrms Series Iii, supplied by Revvity, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ivis lumina xrms series iii/product/Revvity
Average 92 stars, based on 1 article reviews
ivis lumina xrms series iii - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier
precision fluorescence analyzer  (Cellgentek)
95
Cellgentek precision fluorescence analyzer
In vitro, cathepsin B cleavage, cellular toxicity and <t>fluorescence</t> imaging of (Ac)FRRF-DTX NPs. HPLC analysis of (Ac)FRRF-DTX NPs incubated without ( a ) or with ( b ) enzyme reaction buffer containing cathepsin B for different time points (0–72 h). ( c ) LC-MS analysis of PTXm during the cathepsin B cleavage experiment. ( d ) The assessment of cathepsin B activity levels in HDFa, Hep G2, CT26.wt, and A549 cell lines ( n = 3). ( e ) Evaluation of anticancer efficacy on Hep G2 cells treated with DTX, PTX, PTXm, (Ac)FRRF, (Ac)FRRF-DTX NPs and de-Boc-DTX ( n = 5 − 6). ( f ) Cellular uptake of RITC-PTX and RITC-(Ac)FRRF-DTX NPs in Hep G2 cells (Scale bar = 50 μm). ( g ) Data quantifying the fluorescence intensity over time of (Ac)FRRF-DTX NPs and PTX ( n = 3). ( h ) Fluorescent microscopy imaging observing cell death in Hep G2 cells treated with PTX, PTXm and (Ac)FRRF-DTX NPs (Scale bar = 50 μm). ( i ) Quantification of fluorescence intensity from nucleic acid staining using ImageJ software ( n = 5). ( j ) microtubule binding of PTX, PTXm and (Ac)FRRF-DTX NPs (Scale bar = 50 μm). ( k ) Quantification of fluorescence intensity from Microtubule Cytoskeleton Dye using ImageJ software ( n = 5). ( l ) Confocal images of (Ac)FRRF-DTX NPs (Scale bar = 10 μm). *p < 0.05, **p < 0.01 and ***p < 0.001
Precision Fluorescence Analyzer, supplied by Cellgentek, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/precision fluorescence analyzer/product/Cellgentek
Average 95 stars, based on 1 article reviews
precision fluorescence analyzer - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier
ivis lumina imaging system  (Revvity)
94
Revvity ivis lumina imaging system
In vitro, cathepsin B cleavage, cellular toxicity and <t>fluorescence</t> imaging of (Ac)FRRF-DTX NPs. HPLC analysis of (Ac)FRRF-DTX NPs incubated without ( a ) or with ( b ) enzyme reaction buffer containing cathepsin B for different time points (0–72 h). ( c ) LC-MS analysis of PTXm during the cathepsin B cleavage experiment. ( d ) The assessment of cathepsin B activity levels in HDFa, Hep G2, CT26.wt, and A549 cell lines ( n = 3). ( e ) Evaluation of anticancer efficacy on Hep G2 cells treated with DTX, PTX, PTXm, (Ac)FRRF, (Ac)FRRF-DTX NPs and de-Boc-DTX ( n = 5 − 6). ( f ) Cellular uptake of RITC-PTX and RITC-(Ac)FRRF-DTX NPs in Hep G2 cells (Scale bar = 50 μm). ( g ) Data quantifying the fluorescence intensity over time of (Ac)FRRF-DTX NPs and PTX ( n = 3). ( h ) Fluorescent microscopy imaging observing cell death in Hep G2 cells treated with PTX, PTXm and (Ac)FRRF-DTX NPs (Scale bar = 50 μm). ( i ) Quantification of fluorescence intensity from nucleic acid staining using ImageJ software ( n = 5). ( j ) microtubule binding of PTX, PTXm and (Ac)FRRF-DTX NPs (Scale bar = 50 μm). ( k ) Quantification of fluorescence intensity from Microtubule Cytoskeleton Dye using ImageJ software ( n = 5). ( l ) Confocal images of (Ac)FRRF-DTX NPs (Scale bar = 10 μm). *p < 0.05, **p < 0.01 and ***p < 0.001
Ivis Lumina Imaging System, supplied by Revvity, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ivis lumina imaging system/product/Revvity
Average 94 stars, based on 1 article reviews
ivis lumina imaging system - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier
animal fluorescence imaging  (Clinx Science)
94
Clinx Science animal fluorescence imaging
In vitro, cathepsin B cleavage, cellular toxicity and <t>fluorescence</t> imaging of (Ac)FRRF-DTX NPs. HPLC analysis of (Ac)FRRF-DTX NPs incubated without ( a ) or with ( b ) enzyme reaction buffer containing cathepsin B for different time points (0–72 h). ( c ) LC-MS analysis of PTXm during the cathepsin B cleavage experiment. ( d ) The assessment of cathepsin B activity levels in HDFa, Hep G2, CT26.wt, and A549 cell lines ( n = 3). ( e ) Evaluation of anticancer efficacy on Hep G2 cells treated with DTX, PTX, PTXm, (Ac)FRRF, (Ac)FRRF-DTX NPs and de-Boc-DTX ( n = 5 − 6). ( f ) Cellular uptake of RITC-PTX and RITC-(Ac)FRRF-DTX NPs in Hep G2 cells (Scale bar = 50 μm). ( g ) Data quantifying the fluorescence intensity over time of (Ac)FRRF-DTX NPs and PTX ( n = 3). ( h ) Fluorescent microscopy imaging observing cell death in Hep G2 cells treated with PTX, PTXm and (Ac)FRRF-DTX NPs (Scale bar = 50 μm). ( i ) Quantification of fluorescence intensity from nucleic acid staining using ImageJ software ( n = 5). ( j ) microtubule binding of PTX, PTXm and (Ac)FRRF-DTX NPs (Scale bar = 50 μm). ( k ) Quantification of fluorescence intensity from Microtubule Cytoskeleton Dye using ImageJ software ( n = 5). ( l ) Confocal images of (Ac)FRRF-DTX NPs (Scale bar = 10 μm). *p < 0.05, **p < 0.01 and ***p < 0.001
Animal Fluorescence Imaging, supplied by Clinx Science, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/animal fluorescence imaging/product/Clinx Science
Average 94 stars, based on 1 article reviews
animal fluorescence imaging - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier
ivscope7500 luminescence imaging system  (Clinx Science)
94
Clinx Science ivscope7500 luminescence imaging system
In vitro, cathepsin B cleavage, cellular toxicity and <t>fluorescence</t> imaging of (Ac)FRRF-DTX NPs. HPLC analysis of (Ac)FRRF-DTX NPs incubated without ( a ) or with ( b ) enzyme reaction buffer containing cathepsin B for different time points (0–72 h). ( c ) LC-MS analysis of PTXm during the cathepsin B cleavage experiment. ( d ) The assessment of cathepsin B activity levels in HDFa, Hep G2, CT26.wt, and A549 cell lines ( n = 3). ( e ) Evaluation of anticancer efficacy on Hep G2 cells treated with DTX, PTX, PTXm, (Ac)FRRF, (Ac)FRRF-DTX NPs and de-Boc-DTX ( n = 5 − 6). ( f ) Cellular uptake of RITC-PTX and RITC-(Ac)FRRF-DTX NPs in Hep G2 cells (Scale bar = 50 μm). ( g ) Data quantifying the fluorescence intensity over time of (Ac)FRRF-DTX NPs and PTX ( n = 3). ( h ) Fluorescent microscopy imaging observing cell death in Hep G2 cells treated with PTX, PTXm and (Ac)FRRF-DTX NPs (Scale bar = 50 μm). ( i ) Quantification of fluorescence intensity from nucleic acid staining using ImageJ software ( n = 5). ( j ) microtubule binding of PTX, PTXm and (Ac)FRRF-DTX NPs (Scale bar = 50 μm). ( k ) Quantification of fluorescence intensity from Microtubule Cytoskeleton Dye using ImageJ software ( n = 5). ( l ) Confocal images of (Ac)FRRF-DTX NPs (Scale bar = 10 μm). *p < 0.05, **p < 0.01 and ***p < 0.001
Ivscope7500 Luminescence Imaging System, supplied by Clinx Science, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ivscope7500 luminescence imaging system/product/Clinx Science
Average 94 stars, based on 1 article reviews
ivscope7500 luminescence imaging system - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier
fmt2000  (Revvity)
91
Revvity fmt2000
In vitro, cathepsin B cleavage, cellular toxicity and <t>fluorescence</t> imaging of (Ac)FRRF-DTX NPs. HPLC analysis of (Ac)FRRF-DTX NPs incubated without ( a ) or with ( b ) enzyme reaction buffer containing cathepsin B for different time points (0–72 h). ( c ) LC-MS analysis of PTXm during the cathepsin B cleavage experiment. ( d ) The assessment of cathepsin B activity levels in HDFa, Hep G2, CT26.wt, and A549 cell lines ( n = 3). ( e ) Evaluation of anticancer efficacy on Hep G2 cells treated with DTX, PTX, PTXm, (Ac)FRRF, (Ac)FRRF-DTX NPs and de-Boc-DTX ( n = 5 − 6). ( f ) Cellular uptake of RITC-PTX and RITC-(Ac)FRRF-DTX NPs in Hep G2 cells (Scale bar = 50 μm). ( g ) Data quantifying the fluorescence intensity over time of (Ac)FRRF-DTX NPs and PTX ( n = 3). ( h ) Fluorescent microscopy imaging observing cell death in Hep G2 cells treated with PTX, PTXm and (Ac)FRRF-DTX NPs (Scale bar = 50 μm). ( i ) Quantification of fluorescence intensity from nucleic acid staining using ImageJ software ( n = 5). ( j ) microtubule binding of PTX, PTXm and (Ac)FRRF-DTX NPs (Scale bar = 50 μm). ( k ) Quantification of fluorescence intensity from Microtubule Cytoskeleton Dye using ImageJ software ( n = 5). ( l ) Confocal images of (Ac)FRRF-DTX NPs (Scale bar = 10 μm). *p < 0.05, **p < 0.01 and ***p < 0.001
Fmt2000, supplied by Revvity, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fmt2000/product/Revvity
Average 91 stars, based on 1 article reviews
fmt2000 - by Bioz Stars, 2026-04
91/100 stars
  Buy from Supplier
ivscope 7000 plant in vivo imaging system  (Clinx Science)
93
Clinx Science ivscope 7000 plant in vivo imaging system
In vitro, cathepsin B cleavage, cellular toxicity and <t>fluorescence</t> imaging of (Ac)FRRF-DTX NPs. HPLC analysis of (Ac)FRRF-DTX NPs incubated without ( a ) or with ( b ) enzyme reaction buffer containing cathepsin B for different time points (0–72 h). ( c ) LC-MS analysis of PTXm during the cathepsin B cleavage experiment. ( d ) The assessment of cathepsin B activity levels in HDFa, Hep G2, CT26.wt, and A549 cell lines ( n = 3). ( e ) Evaluation of anticancer efficacy on Hep G2 cells treated with DTX, PTX, PTXm, (Ac)FRRF, (Ac)FRRF-DTX NPs and de-Boc-DTX ( n = 5 − 6). ( f ) Cellular uptake of RITC-PTX and RITC-(Ac)FRRF-DTX NPs in Hep G2 cells (Scale bar = 50 μm). ( g ) Data quantifying the fluorescence intensity over time of (Ac)FRRF-DTX NPs and PTX ( n = 3). ( h ) Fluorescent microscopy imaging observing cell death in Hep G2 cells treated with PTX, PTXm and (Ac)FRRF-DTX NPs (Scale bar = 50 μm). ( i ) Quantification of fluorescence intensity from nucleic acid staining using ImageJ software ( n = 5). ( j ) microtubule binding of PTX, PTXm and (Ac)FRRF-DTX NPs (Scale bar = 50 μm). ( k ) Quantification of fluorescence intensity from Microtubule Cytoskeleton Dye using ImageJ software ( n = 5). ( l ) Confocal images of (Ac)FRRF-DTX NPs (Scale bar = 10 μm). *p < 0.05, **p < 0.01 and ***p < 0.001
Ivscope 7000 Plant In Vivo Imaging System, supplied by Clinx Science, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ivscope 7000 plant in vivo imaging system/product/Clinx Science
Average 93 stars, based on 1 article reviews
ivscope 7000 plant in vivo imaging system - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

Image Search Results


In vitro, cathepsin B cleavage, cellular toxicity and fluorescence imaging of (Ac)FRRF-DTX NPs. HPLC analysis of (Ac)FRRF-DTX NPs incubated without ( a ) or with ( b ) enzyme reaction buffer containing cathepsin B for different time points (0–72 h). ( c ) LC-MS analysis of PTXm during the cathepsin B cleavage experiment. ( d ) The assessment of cathepsin B activity levels in HDFa, Hep G2, CT26.wt, and A549 cell lines ( n = 3). ( e ) Evaluation of anticancer efficacy on Hep G2 cells treated with DTX, PTX, PTXm, (Ac)FRRF, (Ac)FRRF-DTX NPs and de-Boc-DTX ( n = 5 − 6). ( f ) Cellular uptake of RITC-PTX and RITC-(Ac)FRRF-DTX NPs in Hep G2 cells (Scale bar = 50 μm). ( g ) Data quantifying the fluorescence intensity over time of (Ac)FRRF-DTX NPs and PTX ( n = 3). ( h ) Fluorescent microscopy imaging observing cell death in Hep G2 cells treated with PTX, PTXm and (Ac)FRRF-DTX NPs (Scale bar = 50 μm). ( i ) Quantification of fluorescence intensity from nucleic acid staining using ImageJ software ( n = 5). ( j ) microtubule binding of PTX, PTXm and (Ac)FRRF-DTX NPs (Scale bar = 50 μm). ( k ) Quantification of fluorescence intensity from Microtubule Cytoskeleton Dye using ImageJ software ( n = 5). ( l ) Confocal images of (Ac)FRRF-DTX NPs (Scale bar = 10 μm). *p < 0.05, **p < 0.01 and ***p < 0.001

Journal: Nano Convergence

Article Title: Tumor-specific biochemical nanoconversion of self-assembled peptide-conjugated paclitaxel-docetaxel-based nanoparticles

doi: 10.1186/s40580-025-00487-0

Figure Lengend Snippet: In vitro, cathepsin B cleavage, cellular toxicity and fluorescence imaging of (Ac)FRRF-DTX NPs. HPLC analysis of (Ac)FRRF-DTX NPs incubated without ( a ) or with ( b ) enzyme reaction buffer containing cathepsin B for different time points (0–72 h). ( c ) LC-MS analysis of PTXm during the cathepsin B cleavage experiment. ( d ) The assessment of cathepsin B activity levels in HDFa, Hep G2, CT26.wt, and A549 cell lines ( n = 3). ( e ) Evaluation of anticancer efficacy on Hep G2 cells treated with DTX, PTX, PTXm, (Ac)FRRF, (Ac)FRRF-DTX NPs and de-Boc-DTX ( n = 5 − 6). ( f ) Cellular uptake of RITC-PTX and RITC-(Ac)FRRF-DTX NPs in Hep G2 cells (Scale bar = 50 μm). ( g ) Data quantifying the fluorescence intensity over time of (Ac)FRRF-DTX NPs and PTX ( n = 3). ( h ) Fluorescent microscopy imaging observing cell death in Hep G2 cells treated with PTX, PTXm and (Ac)FRRF-DTX NPs (Scale bar = 50 μm). ( i ) Quantification of fluorescence intensity from nucleic acid staining using ImageJ software ( n = 5). ( j ) microtubule binding of PTX, PTXm and (Ac)FRRF-DTX NPs (Scale bar = 50 μm). ( k ) Quantification of fluorescence intensity from Microtubule Cytoskeleton Dye using ImageJ software ( n = 5). ( l ) Confocal images of (Ac)FRRF-DTX NPs (Scale bar = 10 μm). *p < 0.05, **p < 0.01 and ***p < 0.001

Article Snippet: Also, the fluorescence intensity in nude mice was captured using a precision fluorescence analyzer (FOBI, CELLGENTEK, Republic of Korea).

Techniques: In Vitro, Fluorescence, Imaging, Incubation, Liquid Chromatography with Mass Spectroscopy, Activity Assay, Microscopy, Staining, Software, Binding Assay

In vivo biodistribution and retention level in the bloodstream of (Ac)FRRF-DTX NPs. ( a ) Scheme describing the in vivo distribution study of (Ac)FRRF-DTX NPs using BALB/c nude mice. ( b ) In vivo distribution over time of RITC-(Ac)FRRF-DTX NPs administered via tail vein injection in BALB/c nude mice. ( c ) Quantified graphs depicting fluorescent intensity in tumor regions ( n = 3). Images showing the measurement of fluorescence intensity from hourly extractions of organs and tumors in mice treated with RITC-(Ac)FRRF-DTX NPs ( d ) and treated with RITC-de-Boc-DTX ( e ). ( f ) Quantified graphs depicting fluorescent intensity in tumor tissues over time ( n = 3). ( g ) The concentration in the bloodstream of Sprague-Dawley rats treated with RITC-(Ac)FRRF-DTX NPs and RITC-de-Boc-DTX administered via tail vein injection ( n = 3). The AUC (h) and half-life (i) ( n = 3). *p < 0.05, **p < 0.01 and ***p < 0.001

Journal: Nano Convergence

Article Title: Tumor-specific biochemical nanoconversion of self-assembled peptide-conjugated paclitaxel-docetaxel-based nanoparticles

doi: 10.1186/s40580-025-00487-0

Figure Lengend Snippet: In vivo biodistribution and retention level in the bloodstream of (Ac)FRRF-DTX NPs. ( a ) Scheme describing the in vivo distribution study of (Ac)FRRF-DTX NPs using BALB/c nude mice. ( b ) In vivo distribution over time of RITC-(Ac)FRRF-DTX NPs administered via tail vein injection in BALB/c nude mice. ( c ) Quantified graphs depicting fluorescent intensity in tumor regions ( n = 3). Images showing the measurement of fluorescence intensity from hourly extractions of organs and tumors in mice treated with RITC-(Ac)FRRF-DTX NPs ( d ) and treated with RITC-de-Boc-DTX ( e ). ( f ) Quantified graphs depicting fluorescent intensity in tumor tissues over time ( n = 3). ( g ) The concentration in the bloodstream of Sprague-Dawley rats treated with RITC-(Ac)FRRF-DTX NPs and RITC-de-Boc-DTX administered via tail vein injection ( n = 3). The AUC (h) and half-life (i) ( n = 3). *p < 0.05, **p < 0.01 and ***p < 0.001

Article Snippet: Also, the fluorescence intensity in nude mice was captured using a precision fluorescence analyzer (FOBI, CELLGENTEK, Republic of Korea).

Techniques: In Vivo, Injection, Fluorescence, Concentration Assay